...
首页> 外文期刊>Current Nanomaterials >Development of Novel Nano Niosomes As Drug Delivery System of Sper-macoce hispida Extract and In Vitro Antituberculosis Activity
【24h】

Development of Novel Nano Niosomes As Drug Delivery System of Sper-macoce hispida Extract and In Vitro Antituberculosis Activity

机译:开发新型纳米学期作为孢子 - 玛科植物肝癌提取物和体外抗亚霉菌活性的药物递送系统

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Tuberculosis bacilli has a highly lipoidal cell, which makes penetration of drugs into the cells difficult leading to the development of resistance, which can be overcome by the use of nanonized niosomal delivery system. Many plants of genus Spermacoce have exhibited antibu-berculosis activity, which has not been tested for S. hispida. Objective: The aim of the present study was to study the antituberculosis activity of Spermacoce hispida extracts and develop novel nano noisome based drug delivery system for the extract of Spermacoce hispida to enhance antituberculosis activity. Method: Thin film hydration technique was employed for the preparation of herbal nano niosomes using different non-ionic surfactants (Span 40 and span 60), cholesterol and suitable solvents. Characterization of niosomes was done using photo micrographs, transmission electron microscopy (TEM), entrapment efficiency, in vitro drug release, physical stability and in vitro antituberculosis activity. Results: Nano niosomes were found to be spherical in shape, which was confirmed by photomicrograph. In the preparation of calibration curve, the extract was found to obey Beer's law in range of 20-50 μg/ mL. Transmission electron micrographs were obtained for selected batches (SCE3, SCE5, SCE6). The vesicles were of varying size 2-3 μm, 1-2 urn and 3-4 μm, respectively. The drug entrapment efficiency for niosomes was observed in the range of 23.4±0.404 to 82.5±0.472 percent. In the sedimentation studies, the niosomes of three batches (SCE4, SCE5 and SCE6) took 75 days to settle. The release of drug from niosomes containing Span 40 was 51% and Span 60 was 53% in 200 min. It was observed that formulation SCE 3 (71±0.351-50±0.528), showed higher stability over the formulation SCE 5 (57±0.432-49±0.642), SCE 6 (59±0.565-33±0.212). Colour changes were not found in all formulations after twelve weeks. In the in vitro antituberculosis activity, formulations SCE3 and SCE6 were effective at 12.5 μg/mL, while SCE5 was effective at 25 μg/mL, which was better than the chloroform extract. Conclusion: The developed niosomal nano-carrier system exhibited prolonged release of drug and enhanced the in vitro antituberculosis activity of Spermacoce hispida extract.
机译:背景:结核病杆菌具有高度类脂细胞,使药物渗入,导致耐药性的发展,这可以通过使用纳米化niosomal输送系统来克服困难的细胞。属丰花草属的许多植物都展出antibu-berculosis活性,未针对S.刚毛测试。目的:本研究的目的是研究丰花草属刚毛的提取物的抗结核活性和开发新型纳米毒害基于药物递送系统,用于丰花草属刚毛的提取物,以提高抗肺结核活性。被采用薄膜水化技术用于使用不同的非离子表面活性剂草药纳米囊泡的制备(司盘40和司盘60),胆固醇和合适的溶剂:方法。囊泡的表征是使用照相显微照片,透射电子显微镜(TEM),包封率,体外药物释放,物理稳定性和体外活性的抗结核完成。结果:纳米囊泡被发现是在形状,这是由显微照片证实球形。在校准曲线的制备中,所述提取物被发现服从比耳定律在20-50微克/毫升的范围内。对选定批次(SCE3,SCE5,SCE6)获得透射电子显微照片。囊泡是不同大小2-3微米,1-2瓮和3-4微米,分别的。在23.4±0.404的范围内,观察到82.5±0.472%的类脂质体的药物包封率。在泥沙研究中,三个批次(SCE4,SCE5和SCE6)的囊泡了75天定居。药物从含跨度40囊泡的释放率为51%和司盘60是在200分钟53%。据观察,制剂SCE 3(71±0.351-50±0.528),显示出超过该制剂SCE 5(57±0.432-49±0.642)更高的稳定性,SCE 6(59±0.565-33±0.212)。在所有配方中12周以后,未发现颜色变化。在体外抗结核活性,制剂SCE3和SCE6是有效的为12.5微克/毫升,而SCE5在25微克/毫升,比氯仿提取物更好的效果。结论:发达niosomal纳米载体系统表现出延长药物的释放和增强中丰花草属刚毛提取物的体外抗结核活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号